U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213648) titled 'Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)' on Oct. 02.
Brief Summary: The purpose of this study is to assess preliminary efficacy of a tailored cognitive bias modification for interpretation (CBM-I) app for reducing anxiety in Huntington's disease and Parkinson's disease.
Study Start Date: Oct., 2025
Study Type: INTERVENTIONAL
Condition:
Huntington Disease
Parkinson Disease
Intervention:
BEHAVIORAL: MindTrails-Movement
CBM-I training app with active CBM-I training condition
OTHER: Waitlist Control
Version of MindTrails-Movement app including surveys and list...